Longevity and aging. Role of free radicals and xanthine oxidase. A review

Pathologie Biologie

Volumn 62, Issue 2, 2014, Pages 61-66

  Labat Robert, J ^a   Robert, L ^a  

^a HÔTEL DIEU   (France)

Author keywords

Aging; Allopurinol; Cardiovascular disease; Free radicals; Ischemia reperfusion; Longevity; Xanthine oxidase

Indexed keywords

ALLOPURINOL; ELASTIN; FIBRONECTIN; FREE RADICAL; INSULIN; SIRTUIN; SIRTUIN 1; SIRTUIN 2; SIRTUIN 3; SIRTUIN 4; SIRTUIN 5; SIRTUIN 6; SOMATOMEDIN; XANTHINE OXIDASE; ANTIOXIDANT; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; SOMATOMEDIN C; TARGET OF RAPAMYCIN KINASE; TISSUE EXTRACT;

AGE; AGING; ARTICLE; CALORIC RESTRICTION; ELASTIC FIBER; ENZYME ACTIVITY; ENZYME INHIBITION; EXTRACELLULAR MATRIX; GLYCATION; HUMAN; LIFE EXTENSION; LONGEVITY; NONHUMAN; PROTEIN DEGRADATION; PROTEIN SYNTHESIS; REPERFUSION INJURY; ANIMAL; ANTAGONISTS AND INHIBITORS; ENZYMOLOGY; GENETICS; METABOLISM; MYOCARDIAL REPERFUSION INJURY; OXIDATIVE STRESS; PHYSIOLOGY;

AGING; ALLOPURINOL; ANIMALS; ANTIOXIDANTS; FREE RADICALS; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR I; LONGEVITY; MAILLARD REACTION; MYOCARDIAL REPERFUSION INJURY; OXIDATIVE STRESS; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES; TISSUE EXTRACTS; TOR SERINE-THREONINE KINASES; XANTHINE OXIDASE;

EID: 84898492866     PISSN: 03698114     EISSN: 17683114     Source Type: Journal    
DOI: 10.1016/j.patbio.2014.02.009     Document Type: Article

References (40)

1. Edeas M. Anti-oxydants, controversies et perspectives: comment expliquer l'échec des études cliniques utilisant des anti-oxydants. J Soc Biol 2009, 203:271-280.
2. Robert L. Les temps de la vie 2002, Flammarion, Paris.
3. Pline. Histoire naturelle. Traduite en françois, avec le texte latin, Tome Troisième A Paris, Veuve Desaint, Librairie rue du Foin, MDCCLXXI Avec approbation et privilege du Roi Traduite en françois, avec le texte latin.
4. Robert L. Calorie-restriction and longevity. End of a dream, at least for primates. Eur Geriatr Med 2013, 4:129-132.
5. McCay C.M., Maynard L.A., Sperling G., Barnes I.L. Retarded growth, lifespan, ultimate body size and age changes in the albino rat after feeding diets restricted in calories. J Nutr 1939, 18:1-13.
6. Mechanisms of dietary restriction in aging and disease 2007, Karger, Basel, Basel. C.V. Mobbs, K. Yen, P.R. Hof (Eds.).
7. Wood J.G., Rogina B., Lavu S., Howitz K., Helfand S.L., Tatar M., et al. Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature 2004, 430:686-689.
8. Hekimi S., Guarente L. Genetics and the specificity of the aging process. N E J Med 2011, 364:2235-2244.
9. Johnson S.C., Rabinovitch P.S., Kaeberlein M. mTOR is a key modulator of ageing and age-related disease. Nature 2013, 493:338-345.
10. Kenyon C.J. The genetics of ageing. Nature 2010, 464:465-470.
11. Segal N.L. The Landmark Minnesota twin study 2012, Harvard University Press, Cambridge, USA.
12. Robert L. Longevity and aging, genetic and post-genetic mechanisms. Which target to choose for postponing and treating age-related diseases. Eur Geriatr Med 2012, 3:61-66.
13. Finch C.E. Longevity, senescence and the genome 1990, The University of Chicago Press, Chicago.
14. Comfort A. The biology of denescence. Churchill Livingstone, 1979.
15. Olsson AG. Atherosclerosis biology and clinical science. Churchill Livingstone, 1987.
16. Vallin J., Meslé F. Vivre au-delà de 100ans. Popul Soc 2001, 365. [rapport INED].
17. Mattison J.A., Roth G.S., Beasley M., Timont E.M., et al. Impact of caloric restriction on health and survival in rhesus monkeys from the NIA study. Nature 2012, 489:318-322.
18. Robert L. Le vieillissement. Faits et théories 1995, Dominos, Flammarion.
19. Weale R. Have human biological functions evolved in support of lifespan?. Mech Age Dev 1993, 69:65-77.
20. Gershon D., Rott R. Studies on the nature of faulty protein molecules and their diminished degradation in cells of aging organisms: functional implications. The 1988 Sandoz lectures in gerontology. Crossroads in aging 1988, Academic Press, London. M. Bergener, M. Ermini, H.B. Stähelin (Eds.).
21. Hornebeck W., Derouette J.C., Roland J., Chatelet F., Bouissou H., Robert L. Corrélation entre l'âge, l'arteriosclérose et l'activité élastinolytique de la paroi aortique humaine. C R Acad Sci 1976, 292:2003-2006.
22. Robert L. Aging of the vascular wall and atherosclerosis. Exp Gerontol 1999, 34:491-501.
23. Robert L., Labat-Robert J., Robert A.M. The Maillard Reaction. From nutritional problems to preventive medicine. Pathol Biol 2010, 58:200-206.
24. Robert L. Fritz Verzar was born 120years ago: his contribution to experimental gerontology through the collagen research as assessed after half a century. Arch Gerontol Geriatr 2006, 43:13-43.
25. Péterszegi G., Molinari J., Ravelojaona V., Robert L. Effect of advanced glycation end-products on cell proliferation and cell death. Pathol Biol 2006, 54:396-404.
26. Robert L., Robert A.M., Renard G. Biological effects of hyaluronan in connective tissues, eye, skin; venous wall. Role in aging. Pathol Biol 2010, 58:187-198.
27. Robert L., Robert A.M., Labat-Robert J. The Maillard reaction - Illicite (bio)chemistry in tissues and food. Pathol Biol 2011, 59:321-328.
28. Anversa P., Hauss W., Wissler R.W., Robert L. Aging of the cardiovascular system. Pathol Biol 1996, 44:312-320.
29. Labat-Robert J. Cell-matrix interactions in aging: role of receptors and matricryptins. Age Res Rev 2004, 3:233-247.
30. Antia M., Baneyx G., Kubow K.E., Vogel V. Fibronectin aging extracellular matrix fibrils is progressively unfolded by cells and elicits an enhanced rigidity response. Faraday Discuss 2008, 139:229-420.
31. Robert L., Labat-Robert J., Hornebeck W. Aging and atherosclerosis. Atherosclerosis reviews 1986, 14. Raven Press, New York.
32. Labat-Robert J., Fourtanier A., Boyer-Lafargue B., Robert L. Age dependent increase of elastase type protease activity in mouse skin. Effect of UV irradiation. Pathol Biol 2000, 57:1132-2118.
33. Bizbiz L., Alperovitch A., Robert L. Aging of the vascular wall: serum concentration of elastin peptides and elastase inhibitors in relation with cardiovascular risk factor. The EVA study. Atherosclerosis 1997, 131:73-78. EVA group.
34. Robert L., Hornebeck W. Interaction between elastic fibers and cells. Frontiers of matrix biology 1986, 11:58-77. Karger, Basel.
35. Varga Z., Jacob M.P., Robert L., Fülöp T. Identification and signal transduction mechanism of elastin peptide receptor in human leucocytes. FEBS Lett 1989, 258:5-8.
36. Fülöp T., Jacob M.P., Khalil A., Wallach J., Robert L. Biological effects of elastin peptides. Pathol Biol 1998, 46:497-506.
37. Elastin and elastases 1989, I-II. CRC Press, Boca Raton.
38. Free radicals and aging 1992, Birkhäuser Verlag, Basel. I. Emerit, B. Chance (Eds.).
39. 2 consumption can explain the simultaneous presence of high longevity and high aerobic metabolic rate in birds. Free Rad Res 1994, 21:317-328.
40. Robert A.M., Robert L. Xanthine oxido-reductase, free radicals and cardiovascular disease. A critical review. Pathol Oncol Res 2013, [10.1007/s12263-013-9698-x].